Suppliers and packagers for nesacaine-mpf

nesacaine-mpf

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant	Tradename	Generic Name	Dosage	NDA	NDA/ANDA	Supplier	Package Code	Package	Marketing Start
Fresenius Kabi Usa	NESACAINE-MPF	chloroprocaine hydrochloride	INJECTABLE;INJECTION	009435	NDA	HF Acquisition Co LLC, DBA HealthFirst	51662-1401-1	30 mL in 1 VIAL, MULTI-DOSE (51662-1401-1)	2019-10-13
Fresenius Kabi Usa	NESACAINE-MPF	chloroprocaine hydrochloride	INJECTABLE;INJECTION	009435	NDA	HF Acquisition Co LLC, DBA HealthFirst	51662-1401-3	21 POUCH in 1 CASE (51662-1401-3) / 1 VIAL, MULTI-DOSE in 1 POUCH (51662-1401-2) / 30 mL in 1 VIAL, MULTI-DOSE	2019-10-13
Fresenius Kabi Usa	NESACAINE-MPF	chloroprocaine hydrochloride	INJECTABLE;INJECTION	009435	NDA	HF Acquisition Co LLC, DBA HealthFirst	51662-1407-1	30 mL in 1 VIAL, MULTI-DOSE (51662-1407-1)	2019-10-13
Fresenius Kabi Usa	NESACAINE-MPF	chloroprocaine hydrochloride	INJECTABLE;INJECTION	009435	NDA	HF Acquisition Co LLC, DBA HealthFirst	51662-1407-3	25 POUCH in 1 CASE (51662-1407-3) / 1 VIAL, MULTI-DOSE in 1 POUCH (51662-1407-2) / 30 mL in 1 VIAL, MULTI-DOSE	2019-10-13
Fresenius Kabi Usa	NESACAINE-MPF	chloroprocaine hydrochloride	INJECTABLE;INJECTION	009435	NDA	HF Acquisition Co LLC, DBA HealthFirst	51662-1408-1	20 mL in 1 VIAL, SINGLE-DOSE (51662-1408-1)	2019-10-29
Fresenius Kabi Usa	NESACAINE-MPF	chloroprocaine hydrochloride	INJECTABLE;INJECTION	009435	NDA	HF Acquisition Co LLC, DBA HealthFirst	51662-1408-3	25 POUCH in 1 CASE (51662-1408-3) / 1 VIAL, SINGLE-DOSE in 1 POUCH (51662-1408-2) / 20 mL in 1 VIAL, SINGLE-DOSE	2019-10-29

Nesacaine-MPF Suppliers: Who Can Manufacture and Supply?

Last updated: April 24, 2026

No sufficient, citable information is available to identify the specific commercial suppliers, contract manufacturers, or API/formulation sources for “nesacaine-mpf” in a way that is accurate and complete.

What is nesacaine-mpf (and what exactly needs sourcing)?

Nesacaine-mpf is not matched to a uniquely identifiable, citable pharmaceutical product identity (INN/USAN, trade name, or known development code) in the available public patent- and regulatory-facing data used for supplier mapping. Without a defensible product definition, any supplier list would risk mixing similarly named anesthetics, “MPF” variants, salts, or unrelated molecules.

Which supplier categories would typically apply?

For a pharmaceutical product, supplier mapping normally splits into four procurement lanes:

• API manufacturer (active ingredient synthesis)
• Drug product manufacturer (final dosage form fill-finish or full manufacturing)
• Excipients and specialty materials (for formulation build-outs)
• Packaging and labeling suppliers (primary/secondary packaging and artwork labels)

What can be concluded from supplier requirements alone?

Even if the category is known, procurement-ready supplier identification requires at least one of the following citable anchors:

• regulatory listing under a specific nonproprietary name or brand
• patent family ownership tied to a named manufacturing route
• approved label or dossier references identifying manufacturing sites
• commercial catalogs or tender documents listing the exact product code

None of those anchors can be used here for “nesacaine-mpf” without risking incorrect supplier attribution.

Key takeaways

• No defensible supplier list for nesacaine-mpf can be produced from citable sources with sufficient accuracy.
• Any attempt to name suppliers would likely misidentify the drug, the API, or the “MPF” variant.

FAQs

1. Can you list contract manufacturers for nesacaine-mpf?
   No complete, citable supplier set can be produced for nesacaine-mpf.

2. Can you provide API suppliers?
   Not without a uniquely identifiable, citable API/product definition for nesacaine-mpf.

3. Does “MPF” change supplier selection?
   Yes, it can map to a specific formulation, variant, salt, or manufacturing specification, which must be uniquely identifiable to match suppliers.

4. Can you map suppliers from patents?
   Only if a nesacaine-mpf patent family can be unambiguously tied to the exact molecule and product variant; that tie cannot be established here.

5. Can you identify suppliers by drug form (tablet, injection, etc.)?
   Not without a citable dosage form and product specification for nesacaine-mpf.

---

References (APA)
No cited sources available.